Genetic susceptibility to aseptic loosening following total hip arthroplasty: a systematic review.

Introduction Aseptic loosening is the most common cause of total hip arthroplasty (THA) failure and revision surgery. Genetic polymorphisms could be determinant factors for implant loosening. Source of data We performed a comprehensive search of Medline, CINAHL, Googlescholar, Embase and Cochrane databases, using various combinations of the keyword terms 'aseptic loosening', 'gene', 'hip arthoplasty', 'genetics', 'loosening'. Twelve studies detailing the genetic investigation of patients with aseptic loosening of a THA were identified. Areas of agreement SNPs of GNAS1, TNF-238 A allele, TNF-α promoter (-308G→A) transition, IL6-174 G allele, interleukin (IL)-6 (-597) and (-572), MMP-1-promoting gene, C/C genotype for the MMP1, MT1-MMP, MMP-2, transforming growth factor-beta1 signal sequence (29T→C) transitions, A/A genotype for the OPG-163, and MBL were overexpressed in patients with aseptic loosening and periprosthetic osteolysis. Areas of controversy Data from single centre studies do not allow one to compare the results of different studies. Conclusion Several gene pathways and genes contribute to the genetic susceptibility to aseptic loosening following THA. Further studies will enhance the understanding of prosthesis failure, and may inform and direct pharmaceutical interventions. Growing points Further multi-centre prospective studies are necessary to confirm the general validity of the findings reported. Single-centre findings should be replicated in other centres and populations to open new avenues for pre-surgical genetic testing and to investigate immune response modulation in THA. Areas timely for developing research Research in this field could lead to better understanding of mechanisms behind aseptic osteolysis, and improve the results of THA.

[1]  J. Gallo,et al.  Functional variants of the P2RX7 gene, aseptic osteolysis, and revision of the total hip arthroplasty: a preliminary study. , 2010, Human immunology.

[2]  J. Gallo,et al.  Variation in cytokine genes can contribute to severity of acetabular osteolysis and risk for revision in patients with ABG 1 total hip arthroplasty: a genetic association study , 2009, BMC Medical Genetics.

[3]  H. Nückel,et al.  BCL2-938C > A and CALCA-1786T > C polymorphisms in aseptic loosened total hip arthroplasty , 2009, European journal of medical research.

[4]  G. Camanho,et al.  Aseptic loosening of total hip arthroplasty: preliminary genetic investigation. , 2009, The Journal of arthroplasty.

[5]  M. Berend,et al.  Sport activity after total hip arthroplasty: changes in surgical technique, implant design, and rehabilitation. , 2009, Journal of sport rehabilitation.

[6]  J. Ioannidis,et al.  STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement , 2009, PLoS medicine.

[7]  U. Frey,et al.  Gender‐dependent association of the GNAS1 T393C polymorphism with early aseptic loosening after total hip arthroplasty , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[8]  R. Eastell,et al.  Polymorphisms in the interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplasty. , 2008, Arthritis and rheumatism.

[9]  S. Bredow,et al.  Identification of a novel Bcl-2 promoter region that counteracts in a p53-dependent manner the inhibitory P2 region. , 2007, Gene.

[10]  John P A Ioannidis,et al.  On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies. , 2007, International journal of epidemiology.

[11]  A. Bayat,et al.  Genetic susceptibility to total hip arthroplasty failure: a preliminary study on the influence of matrix metalloproteinase 1, interleukin 6 polymorphisms and vitamin D receptor , 2007, Annals of the rheumatic diseases.

[12]  R. Gay,et al.  Mechanisms of Disease: molecular insights into aseptic loosening of orthopedic implants , 2007, Nature Clinical Practice Rheumatology.

[13]  A. Bayat,et al.  Genetic susceptibility to total hip arthroplasty failure--positive association with mannose-binding lectin. , 2007, The Journal of arthroplasty.

[14]  K. Pavelić,et al.  Single nucleotide polymorphisms in the interleukin-6 gene promoter, tumor necrosis factor-α gene promoter, and transforming growth factor-β1 gene signal sequence as predictors of time to onset of aseptic loosening after total hip arthroplasty: preliminary study , 2006, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[15]  M. Khoury,et al.  Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. , 2006, American journal of epidemiology.

[16]  D. Thomas,et al.  Are We Ready for Genome-wide Association Studies? , 2006, Cancer Epidemiology Biomarkers & Prevention.

[17]  A. Bayat,et al.  Genetic susceptibility to hip arthroplasty failure—association with the RANK/OPG pathway , 2006, International Orthopaedics.

[18]  Lon R Cardon,et al.  Prospects and pitfalls in whole genome association studies , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.

[19]  Takashi Nakamura,et al.  Deficiency of the G-protein α-Subunit Gsα in Osteoblasts Leads to Differential Effects on Trabecular and Cortical Bone* , 2005, Journal of Biological Chemistry.

[20]  Jie Liu,et al.  Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/en.2004-0865 Minireview: GNAS: Normal and Abnormal Functions , 2022 .

[21]  Kwan Tat Steeve,et al.  IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. , 2004 .

[22]  D. Macdonald,et al.  Variation in the TNF Gene Promoter and Risk of Osteolysis After Total Hip Arthroplasty , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  L. Frommelt,et al.  Receptor activator of nuclear factor κB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening , 2003, Scandinavian journal of rheumatology.

[24]  Muin J Khoury,et al.  The human genome project is complete. How do we develop a handle for the pump? , 2003, American journal of epidemiology.

[25]  J. Gallo,et al.  Particle disease. A comprehensive theory of periprosthetic osteolysis: a review. , 2002, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[26]  S. Cory,et al.  The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.

[27]  H. Ozawa,et al.  Calcitonin gene‐related peptide (CGRP)‐containing nerve fibers in bone tissue and their involvement in bone remodeling , 2002, Microscopy research and technique.

[28]  D. Berry,et al.  Primary uncemented total hip arthroplasty in patients <40 years old: 10- to 14-year results using first-generation proximally porous-coated implants. , 2001, The Journal of arthroplasty.

[29]  A. Rosemurgy,et al.  Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  A. Gafni,et al.  Reliability and Intraoperative Validity of Preoperative Assessment of Standardized Plain Radiographs in Predicting Bone Loss at Revision Hip Surgery , 2001, The Journal of bone and joint surgery. American volume.

[31]  S. Ye.  Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[32]  P. Orcel,et al.  Bone loss: Factors that regulate osteoclast differentiation - an update , 2000, Arthritis Research & Therapy.

[33]  J. Strehle,et al.  The outcome of revision hip arthroplasty in patients older than age 80 years: complications and social outcome of different risk groups. , 2000, The Journal of arthroplasty.

[34]  T. Kishimoto,et al.  Increased Interleukin‐6 Production in Mouse Osteoblastic MC3T3‐E1 Cells Expressing Activating Mutant of the Stimulatory G Protein , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  R. Dubose,et al.  A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function , 1997, Nature.

[36]  G. Kroemer.  The proto-oncogene Bcl-2 and its role in regulating apoptosis , 1997, Nature Medicine.

[37]  G Shimamoto,et al.  Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density , 1997, Cell.

[38]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[39]  M. Petri,et al.  Mannose-binding protein genetic polymorphisms in black patients with systemic lupus erythematosus. , 1996, Arthritis and rheumatism.

[40]  M. Turner,et al.  Mannose-binding lectin: the pluripotent molecule of the innate immune system. , 1996, Immunology today.

[41]  W. Harris,et al.  Revision Total Hip Arthroplasty with Use of So-Called Second-Generation Cementing Techniques for Aseptic Loosening of the Femoral Component. A Fifteen-Year-Average Follow-up Study* , 1996, The Journal of bone and joint surgery. American volume.

[42]  W. Maloney,et al.  Isolation and characterization of wear particles generated in patients who have had failure of a hip arthroplasty without cement. , 1995, The Journal of bone and joint surgery. American volume.

[43]  S. Chavali,et al.  Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. , 1995, Immunology.

[44]  T. Glant,et al.  Response of three murine macrophage populations to particulate debris: Bone resorption in organ cultures , 1994, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[45]  W. Zhong,et al.  EFFECTS OF PROSTAGLANDIN E2 AND CHOLERA TOXIN ON LIPOPOLYSACCHARIDE INDUCED GENE EXPRESSION OF CYTOKINES IN HUMAN MACROPHAGES , 1993 .

[46]  F. P. Magee,et al.  Prostaglandin E2 production by the membrane surrounding loose and fixated cemented tibial hemiarthroplasties in the rabbit knee. , 1992, Clinical orthopaedics and related research.

[47]  W. Harris,et al.  Further follow-up on socket fixation using a metal-backed acetabular component for total hip replacement. A minimum ten-year follow-up study. , 1987, The Journal of bone and joint surgery. American volume.

[48]  W. Harris,et al.  Loosening of the femoral component after use of the medullary-plug cementing technique. Follow-up note with a minimum five-year follow-up. , 1986, The Journal of bone and joint surgery. American volume.

[49]  K. Jöckel,et al.  Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia. , 2007, Blood.

[50]  Paolo Vineis,et al.  A road map for efficient and reliable human genome epidemiology , 2006, Nature Genetics.

[51]  Emily Waltz,et al.  US ponders unlocking the gates to prisoner research , 2006, Nature medicine.

[52]  Takashi Nakamura,et al.  Deficiency of the G-protein alpha-subunit G(s)alpha in osteoblasts leads to differential effects on trabecular and cortical bone. , 2005, The Journal of biological chemistry.

[53]  S. Kwan Tat,et al.  IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. , 2004, Cytokine & growth factor reviews.

[54]  E. Schwarz,et al.  Aseptic loosening , 2004, Gene Therapy.

[55]  D. Chao,et al.  BCL-2 family: regulators of cell death. , 1998, Annual review of immunology.

[56]  A. Baldwin,et al.  The NF-kappa B and I kappa B proteins: new discoveries and insights. , 1996, Annual review of immunology.

[57]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[58]  Y. Kim,et al.  Results of the Harris-Galante cementless hip prosthesis. , 1992, The Journal of bone and joint surgery. British volume.